Weight loss of even a small percentage of body mass tends to return more regular cycles
Retatrutides safety profile is consistent with whats already been observed GLP-1 receptor agonists and combined GLP-1/GIP receptor agonists, meaning the expected side effects are primarily gastrointestinal (GI) in nature: Nausea, vomiting, diarrhea, and constipation
For a detailed comparison of these two tissue repair peptides, see our BPC-157 vs TB-500 research guide
If youre currently on GLP-1 therapy and want to understand where cagrilintide fits into your long-term plan or if youre just starting to explore medical weight loss that conversation starts with a real evaluation
One retrospective study found that 7 of 12 patients with chronic knee pain reported symptom improvement lasting more than 6 months following a single intra-articular BPC-157 injection
TB-500 Blend Peptide combines two extensively studied research peptides involved in cellular repair and tissue signaling pathways